Anavex Life Sciences
AVXL
#9984
Rank
S$97.63 M
Marketcap
S$1.05
Share price
-12.42%
Change (1 day)
-77.35%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2026 (TTM): -S$16.61 Million

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -S$51.52 Million, an increase over its 2024 earnings that were of -S$66.42 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$16.61 Million-67.77%
2025 -S$51.52 Million-22.43%
2024 -S$66.42 Million14.77%
2023 -S$57.87 Million-17.49%
2022 -S$70.14 Million22.96%
2021 -S$57.04 Million35.36%
2020 -S$42.14 Million12.65%
2019 -S$37.41 Million29.09%
2018 -S$28.98 Million36.33%
2017 -S$21.26 Million17.11%
2016 -S$18.15 Million20.91%
2015 -S$15.01 Million-6.29%
2014 -S$16.02 Million337.28%
2013 -S$3.67 Million
2008 -S$6.78 Million106.01%
2007 -S$3.29 Million8848.98%
2006 -S$0.04 Million-79.99%
2005 -S$0.19 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
S$78.46 M-570.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
S$0.14 B-956.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-S$10.79 Million-35.37%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-S$0.46 Billion 2,638.61%๐Ÿ‡บ๐Ÿ‡ธ USA